Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of Mesenchymal Stem Cell-Derived Exosome Therapy in Improving Endothelial Dysfunction in Postpartum Mothers With a History of Preeclampsia

NCT07183384 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT07183384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07183384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of Mesenchymal Stem Cell-Derived Exosome Therapy in Improving Endothelial Dysfunction in Postpartum Mothers With a History of Preeclampsia
Lead sponsor
Universitas Padjadjaran
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 1, 2024
Completion date
September 1, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cell therapy, endothelial injury, exosome multiomics, postpartum, preeclampsia